Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Current Medicinal Chemistry|February 21, 2022
A2A Adenosine Receptor Antagonists and their Potential in Neurological DisordersCatia Lambertucci, Gabriella Marucci, Daniela Catarzi, et al.
Expert Opinion on Therapeutic Patents|November 16, 2019
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applicationsGabriella Marucci, Diego Dal Ben, Michela Buccioni, et al.
Purinergic Signalling|April 12, 2008
Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A₃ adenosine receptor ligandsDiego Dal Ben, Catia Lambertucci, Sara Taffi, et al.
Chemmedchem|January 21, 2010
Molecular modeling studies on the human neuropeptide S receptor and its antagonistsDiego Dal Ben, Ippolito Antonini, Michela Buccioni, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Synthesis and biological activity of trisubstituted adenines as A 2A adenosine receptor antagonistsCatia Lambertucci, Sauro Vittori, Ram Chandra Mishra, et al.
Cells|July 11, 2025
Radioligands Targeting the Purinergic P2X ReceptorsDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.
Chemmedchem|April 1, 2011
Neuropeptide S receptor: recent updates on nonpeptide antagonist discoveryDiego Dal Ben, Ippolito Antonini, Michela Buccioni, et al.
Chemmedchem|November 19, 2016
The G Protein-Coupled Receptor GPR17: Overview and UpdateGabriella Marucci, Diego Dal Ben, Catia Lambertucci, et al.
Molecular Informatics|August 23, 2016
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine ReceptorDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.
Thescientificworldjournal|June 27, 2014
Antiproliferative evaluation of isofuranodiene on breast and prostate cancer cell linesMichela Buccioni, Diego Dal Ben, Catia Lambertucci, et al.
Pageof 10